Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2049)
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
5,000
Price
$8.50
Total Value
$42.50K
Shares Held After
1,361,053
% of Holdings
0.4%
908 Devices Inc. (MASS)
Knopp Kevin J. — Director
Shares
2,747
Price
$10.07
Total Value
$27.66K
Shares Held After
583,590
% of Holdings
0.5%
ICU MEDICAL INC/DE (ICUI)
Sousa Ben — Chief Information Officer
Shares
2,250
Price
$178.32
Total Value
$401.21K
Shares Held After
3,076
% of Holdings
42.2%
STERIS plc (STE)
Sohi Mohsen — Director
Shares
4,058
Price
$235.78
Total Value
$956.80K
Shares Held After
24,305
% of Holdings
14.3%
PFIZER INC (PFE)
BOURLA ALBERT — Director
Shares
38,000
Price
$26.34
Total Value
$1.00M
Shares Held After
429,173
% of Holdings
8.9%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Girshick Birgit — Director
Shares
6,500
Price
$279.90
Total Value
$1.82M
Shares Held After
36,013
% of Holdings
15.3%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
619
Price
$25.00
Total Value
$15.47K
Shares Held After
35,072
% of Holdings
1.7%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Chaudhuri Sarbani — Chief Commercial&Medical Affairs Officer
Shares
4,701
Price
$3.50
Total Value
$16.45K
Shares Held After
262,809
% of Holdings
1.8%
Wave Life Sciences, Inc. (WVE)
Wagner Heidi L — Director
Shares
7,000
Price
$6.01
Total Value
$42.07K
Shares Held After
44,930
% of Holdings
13.5%
Wave Life Sciences, Inc. (WVE)
Tan Aik Na — Director
Shares
432
Price
$6.01
Total Value
$2.60K
Shares Held After
24,968
% of Holdings
1.7%
Wave Life Sciences, Inc. (WVE)
TAKANASHI KEN — Director
Shares
3,864
Price
$6.01
Total Value
$23.22K
Shares Held After
20,079
% of Holdings
16.1%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
2,666
Price
$360.00
Total Value
$959.76K
Shares Held After
0
% of Holdings
100.0%
GLAUKOS Corp (GKOS)
Gilliam Joseph E — PRESIDENT&COO
Shares
32,037
Price
$180.49
Total Value
$5.78M
Shares Held After
72,588
% of Holdings
30.6%
GLAUKOS Corp (GKOS)
Gilliam Joseph E — PRESIDENT&COO
Shares
27,963
Price
$178.89
Total Value
$5.00M
Shares Held After
104,625
% of Holdings
21.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
8,300
Price
$26.52
Total Value
$220.13K
Shares Held After
119,289
% of Holdings
6.5%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
25,000
Price
$44.00
Total Value
$1.10M
Shares Held After
174,209
% of Holdings
12.5%
AMGEN INC (AMGN)
Khosla Rachna — SVP, Business Development
Shares
2,000
Price
$412.57
Total Value
$825.13K
Shares Held After
6,404
% of Holdings
23.8%
ABBOTT LABORATORIES (ABT)
Morrone Louis H. — EXECUTIVE VICE PRESIDENT
Shares
5,850
Price
$109.83
Total Value
$642.51K
Shares Held After
70,724
% of Holdings
7.6%
LifeStance Health Group, Inc. (LFST)
Burdick Kenneth A — Director
Shares
500,000
Price
$11.51
Total Value
$5.75M
Shares Held After
2,970,810
% of Holdings
14.4%
Denali Therapeutics Inc. (DNLI)
Schuth Alexander O. — COFO and Secretary
Shares
2,857
Price
$25.07
Total Value
$71.62K
Shares Held After
281,763
% of Holdings
1.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
368
Price
$13.96
Total Value
$5.14K
Shares Held After
145,937
% of Holdings
0.3%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
1,775
Price
$13.96
Total Value
$24.78K
Shares Held After
704,781
% of Holdings
0.3%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Stevens Christopher James — Chief Operating Officer
Shares
36,658
Price
$3.50
Total Value
$128.27K
Shares Held After
505,784
% of Holdings
6.8%
LivaNova PLC (LIVN)
Tezel Ahmet — Chief Innovation Officer
Shares
2,675
Price
$77.74
Total Value
$207.94K
Shares Held After
6,090
% of Holdings
30.5%
Amneal Pharmaceuticals, Inc. (AMRX)
Daly Jason B. — EVP, Chief Legal Officer
Shares
6,613
Price
$17.70
Total Value
$117.05K
Shares Held After
245,171
% of Holdings
2.6%
10x Genomics, Inc. (TXG)
STUELPNAGEL JOHN R — Director
Shares
3,000
Price
$58.73
Total Value
$176.18K
Shares Held After
348,436
% of Holdings
0.9%
10x Genomics, Inc. (TXG)
STUELPNAGEL JOHN R — Director
Shares
17,000
Price
$57.58
Total Value
$978.88K
Shares Held After
351,436
% of Holdings
4.6%
Medpace Holdings, Inc. (MEDP)
McCarthy Cornelius P. III — Director
Shares
1,140
Price
$605.37
Total Value
$690.12K
Shares Held After
12,275
% of Holdings
8.5%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Parisotto Shannon M — CEVP, Disc&Safety Assessment
Shares
3,714
Price
$279.66
Total Value
$1.04M
Shares Held After
4,807
% of Holdings
43.6%
Xenon Pharmaceuticals Inc. (XENE)
GANNON STEVEN — Director
Shares
10,000
Price
$64.06
Total Value
$640.55K
Shares Held After
1,870
% of Holdings
84.2%
THERMO FISHER SCIENTIFIC INC. (TMO)
Shafer Michael D — Executive Vice President
Shares
14,300
Price
$600.00
Total Value
$8.58M
Shares Held After
20,994
% of Holdings
40.5%
THERMO FISHER SCIENTIFIC INC. (TMO)
Shafer Michael D — Executive Vice President
Shares
11,200
Price
$600.00
Total Value
$6.72M
Shares Held After
20,994
% of Holdings
34.8%
Evogene Ltd. (EVGN)
RECANATI LEON — Director
Shares
460,000
Price
$0.64
Total Value
$292.10K
Shares Held After
1,343,886
% of Holdings
34.2%
Sagimet Biosciences Inc. (SGMT)
Kemble George — Director
Shares
20,206
Price
$9.95
Total Value
$201.15K
Shares Held After
62,161
% of Holdings
24.5%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
2,220
Price
$0.32
Total Value
$710.40
Shares Held After
34,199
% of Holdings
6.5%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
34,239
Price
$148.52
Total Value
$5.09M
Shares Held After
523,478
% of Holdings
6.1%
BIODESIX INC (BDSX)
SCHULER JACK W — 10% Owner
Shares
13,700
Price
$24.01
Total Value
$328.91K
Shares Held After
540,810
% of Holdings
2.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
4
Price
$367.00
Total Value
$1.47K
Shares Held After
54,892
% of Holdings
0.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,200
Price
$366.31
Total Value
$439.57K
Shares Held After
54,896
% of Holdings
2.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,176
Price
$365.26
Total Value
$1.16M
Shares Held After
56,096
% of Holdings
5.4%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
5,211
Price
$364.31
Total Value
$1.90M
Shares Held After
59,272
% of Holdings
8.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
13,403
Price
$363.45
Total Value
$4.87M
Shares Held After
64,483
% of Holdings
17.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
11,568
Price
$362.34
Total Value
$4.19M
Shares Held After
77,886
% of Holdings
12.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
14,569
Price
$361.47
Total Value
$5.27M
Shares Held After
89,454
% of Holdings
14.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
8,081
Price
$360.33
Total Value
$2.91M
Shares Held After
104,023
% of Holdings
7.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
13,695
Price
$359.32
Total Value
$4.92M
Shares Held After
112,104
% of Holdings
10.9%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
62,291
Price
$26.23
Total Value
$1.63M
Shares Held After
0
% of Holdings
100.0%
Amphastar Pharmaceuticals, Inc. (AMPH)
PRINS RICHARD K — Director
Shares
7,973
Price
$20.30
Total Value
$161.85K
Shares Held After
29,625
% of Holdings
21.2%
BECTON DICKINSON&CO (BDX)
Goette Roland — EVP and President, EMEA
Shares
2,438
Price
$180.84
Total Value
$440.89K
Shares Held After
14,856
% of Holdings
14.1%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
6,001
Price
$99.90
Total Value
$599.51K
Shares Held After
36,355
% of Holdings
14.2%
Showing 451–500 of 2049 transactions (page 10 of 41)